PMID- 21920769 OWN - NLM STAT- MEDLINE DCOM- 20120315 LR - 20111121 IS - 1096-0023 (Electronic) IS - 1043-4666 (Linking) VI - 56 IP - 3 DP - 2011 Dec TI - Apheresis-inducible cytokine pattern change in severe, genetic dyslipidemias. PG - 835-41 LID - 10.1016/j.cyto.2011.08.024 [doi] AB - OBJECTIVE: The effects of direct adsorption of lipids LDL-apheresis (DALILDL-a) on plasma cytokines in two Homozygous and heterozygous familial hypercholesterolemic (HozFH, HtzFH) and in four HyperLp(a)lipoproteinemic [HyperLp(a)] patients, were evaluated. METHODS: Plasma, macrophage inflammatory proteins 1alpha (MIP-1alpha), macrophage inflammatory proteins 1beta (MIP-1beta), monocyte chemoattractant protein-1 (MCP-1), RANTES (Regulated upon Activation, Normal T-cell Expressed, and Secreted), granulocyte-colony stimulating factor (GCSF), granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-1alpha (IL-1alpha), interleukin-1beta (IL-1beta), interleukin-2 (IL-2), interleukin-6 (IL-6), interferon-gamma (IFN-gamma), concentrations, were measured before and after LDL-a on three consecutive sessions for each patient. RESULTS: MIP-1alpha was significantly reduced (P=0.05), while MIP-1beta was significantly increased (P=0.05). Plasma MCP-1 was reduced, although not significantly, while RANTES was significantly increased (P=0.05). GCSF and GM-CSF were both significantly reduced (GM-CSF: P=0.05, GCSF: P=0.05, respectively). IL-1alpha level was significantly reduced (P=0.001). IL-1beta, IL-6, and IFN-gamma levels were significantly reduced in plasma after apheresis (IL-1beta: P=0.001, IL-6: T1 P=0.001; T2 P=0.05, respectively, IFN-gamma: P=0.001). IL-2 level in plasma was significantly reduced at T0, and T2, (P=0.001). However, IL-2 level showed a statistically significant increase at T1 (P=0.001). A significant correlation between IL-1alpha and IFN-gamma was found: r=0.882 (P=0.001). CONCLUSIONS: In this study LDL-a induced profound changes in several circulating cytokines and promoted anti-inflammatory and anti-atherogenic cytokine profile in plasma of patients with severe dyslipidemia, with pre-existing angiographically demonstrated Coronary heart disease (CHD), and aortic valvular disease (#=1) (AVD). CI - Copyright (c) 2011 Elsevier Ltd. All rights reserved. FAU - Stefanutti, Claudia AU - Stefanutti C AD - Extracorporeal Therapeutic Techniques Unit-Immunohematology and Transfusion Medicine, Department of Molecular Medicine, University of Rome La Sapienza, Umberto I Hospital, Rome, Italy. cstefanutti@alice.it FAU - Vivenzio, Antonio AU - Vivenzio A FAU - Ferraro, Pietro Manuel AU - Ferraro PM FAU - Morozzi, Claudia AU - Morozzi C FAU - Belotherkovsky, Dany AU - Belotherkovsky D LA - eng PT - Journal Article DEP - 20110914 PL - England TA - Cytokine JT - Cytokine JID - 9005353 RN - 0 (Cytokines) SB - IM MH - Adult MH - *Blood Component Removal MH - Cytokines/*blood MH - Demography MH - Dyslipidemias/*blood/*genetics/immunology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Sample Size EDAT- 2011/09/17 06:00 MHDA- 2012/03/16 06:00 CRDT- 2011/09/17 06:00 PHST- 2011/05/10 00:00 [received] PHST- 2011/08/06 00:00 [revised] PHST- 2011/08/13 00:00 [accepted] PHST- 2011/09/17 06:00 [entrez] PHST- 2011/09/17 06:00 [pubmed] PHST- 2012/03/16 06:00 [medline] AID - S1043-4666(11)00703-4 [pii] AID - 10.1016/j.cyto.2011.08.024 [doi] PST - ppublish SO - Cytokine. 2011 Dec;56(3):835-41. doi: 10.1016/j.cyto.2011.08.024. Epub 2011 Sep 14.